???⭐??? ??⭐?? ??? ??? ?? ??? ???? ???? ??? ???? ?????.

1. ???⭐??? ??⭐?? ??? ??? ?? ??? ???? ???? ??? ???? ?????.27? HR???? ????? ?? ?? 808?? ???? ??? ?? ??? ??? ?? ?? ??? ??? ?? ??? ?? ?? ?? 35.0%? ????. ??? ?? ?? ??? ?? ??(78.8%)?? ?? 43.8%??? ??? ???.

2. ?? ???? ? ????????⭐??? ??⭐??? ????? ??? ????? ??? ??? ????? ??? ???? ??? ? ??? ????.??? ??? ??? ??? A?? ???? ??? ??? ??, A?? ????. ????? ???? A?? ? 4? ??? ??? ??.

3. ????????⭐??? ??⭐?? ???? ib???? ???? 4? ?? ?????? ???? 375? ?? 4600??? 5100??? 9% ???? ????. ?? 2022? ??? ?? ??? ? 10% ?? ? 2? ???. ???? ????? ?? ?? ??? ?? “??? ???? ?? ??? ????? ?? ???? ????”? ???.??? ??? ??? ???? ?? ????????? ?? ?? ??? 27?? ??(??? ??)? ??. ??? “??? ??? ???·??? ???? ??? ????”? ????. ?? ???? ib?? ?? 16 ??????? ??? ?? ??? ????? ?? ??? ??? ??? ?? ??, ??? ?? ? ??? ???? ????.??? ?? ?? ????? ???? ?? ??? ????? ?? PvE ????, ??? ? ?? ????? ???? ???? ???.

4. ????????⭐??? ??⭐how win friends and influence peopleSouth Korea’s GI Innovation said on Monday that it signed a clinical trial collaboration and supply agreement with global pharmaceutical company MSD.Under the agreement, the duo will conduct a trial to evaluate the efficacy of their immunotherapies in combination. The two companies will also evaluate the efficacy of GI Innovation’s immuno-oncology drug GI-102 in combination with MSD’s Keytruda in patients with resistant liver cancer, melanoma, and kidney cancer. 1? 1, 2??? ?? ??? ? ??? ?? ??? ????. ? ?? ?? ????? ??? ???? ???? ?? ??? ?? ??, ??? ???? ???? 4?? ????.